HIV-1 Expression Induces Tubular Cell G2/M Arrest and Apoptosis

REFERENCES

• Bourgoignie JJ, Pardo V. The nephropathology in human immunodeficiency virus (HIV-1) infection. Kidney Int. 1991; 40(Suppl)S19–S23
   Google Scholar
• Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ. Glomerular lesions in acquired immunodeficiency syndrome. Ann Intern Med. 1984; 101: 429–434
   PubMed Web of Science ®Google Scholar
• Rao TKS, Filppone EJ, Nicastri AD, et al. Associated focal segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984; 310: 664–673
   Google Scholar
• Kimmel PL, Phillips TM, Ferreira-Centeno A, Farkas-Szlallasi T, Abraham AA, Garrett CT. HIV-associated immune mediated renal disease. Kidney Int. 1993; 44: 1327–1340
   PubMed Web of Science ®Google Scholar
• Winston JA, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 200001; 344: 1979–1984
   Google Scholar
• Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Inv. 1997; 100: 84–92
   PubMed Web of Science ®Google Scholar
• Cohen AH, Sun NCJ, Shapsak P, Imagawa DT. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol. 1989; 2: 125–128
   PubMed Web of Science ®Google Scholar
• Rappaport J, Kopp JB, Klotman PE. Host virus interactions and the molecular regulation of HIV-1: Role in the pathogenesis of HIV-associated nephropathy. Kidney Int. 1994; 46: 16–27
   Google Scholar
• Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A. HIV-1 kills tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest. 1998; 102: 2041–2049
   PubMed Web of Science ®Google Scholar
• Marras D, Bruggman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klotman PE. Replication and compartalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002; 8: 522–526
   PubMed Web of Science ®Google Scholar
• Kapasi AA, Patel G, Franki N, Singhal PC. HIV-1 gp120-induced tubular epithelial cell apoptosis is mediated through p38-MAPK phosphorylation. Mol Med. 2002; 8: 676–685
   Google Scholar
• Eitner F, Cui Y, Hudkins KL, Stokes MB, Segerer S, Mack M, Lewis PL, Abraham AA, Schlöndorff D, Gallo G, Kimmel PL, Alpers CE. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol. 2000; 11: 856–867
   PubMed Web of Science ®Google Scholar
• Hatsukari I, Singh P, Hitosugi N, Messmer D, Valderrama E, Teichberg S, Chaung W, Gross E, Schmidtmayerova H, Singhal PC. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol. 2007; 18: 780–787
   PubMed Web of Science ®Google Scholar
• Ray PE, Liu XH, Henry D, Dye L, Xu L, Orenstein JM, Schuztbank TE. Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int. 1998; 53: 1217–1229
   PubMed Web of Science ®Google Scholar
• Vogetseder A, Karadeniz A, Kaissling B, Le Hir M. Tubular cell proliferation in the healthy rat kidney. Histochem Cell Biol. Aug, 2005; 124(2)97–104
   PubMed Web of Science ®Google Scholar
• Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, Hishida A. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant. Jan, 2006; 21(1)41–50
   PubMed Web of Science ®Google Scholar
• Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2001; 2(1)21–32
   PubMed Web of Science ®Google Scholar
• Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM. Formation and activation of a cyclinE-cdk2 complex during the G1 phase of the human cell cycle. Science. 1992; 257: 1689–1694
   PubMed Web of Science ®Google Scholar
• Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 2001; 410: 842–847
   PubMed Web of Science ®Google Scholar
• Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle-dependent phosphorylation and subunit rearrangement. Cell. 1988; 54: 17–26
   PubMed Web of Science ®Google Scholar
• Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D. Cdc2 protein kinase is complexed with both cyclin A and B: Evidence for proteolytic inactivation of MPF. Cell. 1989; 56: 829–838
   PubMed Web of Science ®Google Scholar
• Ducommun B, Brambilla P, Felix MA, Franza BR, Jr, Karsenti E, Draetta G. Cdc2 phosphorylation is required for its interaction with cyclin. EMBO J. 1991; 10: 3311–3319
   PubMed Web of Science ®Google Scholar
• Borgne A, Meijer L. Sequential dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the prophase/metaphase transition. J. Biol. Chem. 1996; 271: 27847–27854
   PubMed Web of Science ®Google Scholar
• Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 1997; 277: 1501–1505
   PubMed Web of Science ®Google Scholar
• Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H, Chung JH. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. (USA). 1999; 96: 3745–3750
   PubMedGoogle Scholar
• Aguda BD. A quantitative analysis of the kinetics of the G(2) DNA damage checkpoint system. Proc. Natl. Acad. Sci. (USA). 1999; 96: 11352–11357
   PubMed Web of Science ®Google Scholar
• Hermeking H, Lengauer C, Polyak K, He T, Zhang L, Thiagalingam S. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1997; 1: 3–11
   PubMed Web of Science ®Google Scholar
• Wang XW, Zhan QM, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ, Jr, Harris CC. GADD45 induction of a G(2)/M cell cycle checkpoint. Proc. Natl. Acad. Sci. (USA). 1999; 96: 3706–3711
   PubMed Web of Science ®Google Scholar
• Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995; 80: 293–299
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9: 1799–1805
   PubMed Web of Science ®Google Scholar
• Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 2002; 4: 842–849
   PubMed Web of Science ®Google Scholar
• Nakano K, Vousden KH. Puma, a novel proapoptotic gene, is induced by p53. Mol. Cell. 2001; 7: 683–694
   PubMed Web of Science ®Google Scholar
• Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita Y, Tokino T, Taniguchi T, Tanaka N. Noxa, a BH3-only member of the bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000; 288: 1053–1058
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004; 303: 1010–1014
   PubMed Web of Science ®Google Scholar
• Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003; 33: 357–365
   PubMed Web of Science ®Google Scholar